Zurich Cantonal Bank
CAPR icon

Zurich Cantonal Bank’s Capricor Therapeutics CAPR Stock Holding History

Zurich Cantonal Bank’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309K Hold
12,840
– – ﹤0.01% 2170
2026
Q1 		$390K Buy
+12,840
New +$342K ﹤0.01% 1954
2025
Q3 		– Sell
-13,591
Closed -$135K – 2561
2025
Q2 		$135K Buy
13,591
+345
+3% +$3.64K ﹤0.01% 2293
2025
Q1 		$126K Buy
13,246
+3,162
+31% +$43.9K ﹤0.01% 2308
2024
Q4 		$139K Buy
+10,084
New +$177K ﹤0.01% 2306

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Zurich Cantonal Bank's CAPR Position: Q2 2026 in Review

Zurich Cantonal Bank held its Capricor Therapeutics (CAPR) position steady in Q2 2026 at 12,840 shares worth $309K. The position accounts for ﹤0.01% of the portfolio, ranked #2170.

Zurich Cantonal Bank first reported a position in CAPR in Q4 2024 and has held it in 5 quarters since. The position peaked at $390K in Q1 2026. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Zurich Cantonal Bank held 12,840 shares of Capricor Therapeutics worth $309K as of Q2 2026.
  • Zurich Cantonal Bank left its Capricor Therapeutics share count unchanged in Q2 2026.
  • Capricor Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2170 holding.
  • Zurich Cantonal Bank first reported a position in Capricor Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • Zurich Cantonal Bank's Capricor Therapeutics position peaked at $390K in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.